Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2026178 | 0.86 | LMNA (0.52) | LMNA | |
| SCHEMBL92233 | 0.82 | LMNA (0.48) | LMNA | |
| SCHEMBL15632756 | 0.82 | LMNA (0.48) | LMNA | |
| SCHEMBL17707711 | 0.79 | LMNA (0.45) | LMNA | |
| SCHEMBL13875108 | 0.79 | LMNA (0.45) | LMNA | |
| SCHEMBL5076396 | 0.77 | LMNA (0.43) | LMNA | |
| SCHEMBL92189 | 0.74 | LMNA (0.45) | LMNA | |
| SCHEMBL9636037 | 0.73 | GSR (0.44) | LMNA | |
| SCHEMBL10453157 | 0.73 | LMNA (0.39) | LMNA | |
| SCHEMBL10983140 | 0.72 | LMNA (0.38) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080131420-A1 | METHODS AND COMPOSITIONS FOR TREATING MUCOSAL INFLAMMATION | ACCENTIA, INC. (US) | 2008-06-05 | — | — | US | disclosed |
| WO-2008008494-A2 | METHODS AND COMPOSITIONS FOR TREATING MUCOSAL INFLAMMATION | ACCENTIA BIOPHARMACEUTICALS, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-0744171-B1 | DENTAL COMPOSITION FOR HYPERSENSITIVE DENTIN | SUN MEDICAL CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| EP-0721773-B1 | Dental composition for relieving dentin hypersensitivity | SUN MEDICAL CO LTD (JP) | 2002-03-27 | — | — | EP | disclosed |
| US-5879663-A | Dental composition for dentin hypersensitivity | SUN MEDICAL CO., LTD. (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0744171-A1 | DENTAL COMPOSITION FOR HYPERSENSITIVE DENTIN | SUN MEDICAL CO., LTD. (JP) | 1996-11-27 | — | — | EP | disclosed |
| EP-0721773-A2 | Dental composition for relieving dentin hypersensitivity | SUN MEDICAL CO., LTD. (JP) | 1996-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080131420-A1 | METHODS AND COMPOSITIONS FOR TREATING MUCOSAL INFLAMMATION | MMP8, MUC1, MPO | LMNA 3464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.